Carolyn Owen
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 68
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 68
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 14
- Acute Myeloid Leukemia Research 7
- Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 19
- Oncology top 5%
- Viral-associated cancers and disorders 8
-
- Acute Lymphoblastic Leukemia research 14
-
- CNS Lymphoma Diagnosis and Treatment 10
- Co-authors
- John F. SeymourThomas J. KippsPeter HillmenTadeusz RobakJude FitzgibbonDouglas A. StewartMichael J. BarnettArnon P. Kater
- Journals
- New England Journal of Medicine (3 papers)Journal of Clinical Oncology (8 papers)Blood (26 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Carolyn Owen
90 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Genetics 2.1k
- Pathology and Forensic Medicine 1.8k
- Hematology 989
- Immunology 782
- Oncology 702
Countries citing papers authored by Carolyn Owen
This map shows the geographic impact of Carolyn Owen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn Owen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn Owen more than expected).
Fields of papers citing papers by Carolyn Owen
This network shows the impact of papers produced by Carolyn Owen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn Owen. The network helps show where Carolyn Owen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carolyn Owen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 9 | |
| 10 | Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia breakdown → | 2022 | 146 |
| 11 | 2021 | 0 | |
| 12 | 2020 | 6 | |
| 13 | Obinutuzumab for the First-Line Treatment of Follicular Lymphomabreakdown → | 2017 | 461 |
| 14 | Improvement in hematologic function, disease burden/symptoms with ibrutinib in older treatment-naive (TN) patients with chronic lymphocytic leukemia (CLL) in phase 3 RESONATE-2 (TM) | 2016 | 1 |
| 15 | 2015 | 1 | |
| 16 | 2015 | 3 | |
| 17 | 2012 | 64 | |
| 18 | 2012 | 61 | |
| 19 | 2011 | 90 | |
| 20 | 2008 | 168 |
About Carolyn Owen
Carolyn Owen is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 99 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (68 papers), Lymphoma Diagnosis and Treatment (68 papers), Immunodeficiency and Autoimmune Disorders (19 papers), Chronic Myeloid Leukemia Treatments (14 papers), Acute Lymphoblastic Leukemia research (14 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (8 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Genetics (2.1k citations), Pathology and Forensic Medicine (1.8k citations) and Hematology (989 citations). Carolyn Owen has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include John F. Seymour, Thomas J. Kipps, Peter Hillmen, Tadeusz Robak, Jude Fitzgibbon, Douglas A. Stewart, Michael J. Barnett, Arnon P. Kater, Michelle Boyer and Barbara Eichhorst. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.